[NN4101]

[iOVS] Intraocular Concentration of Stem Cell Factor/c-KIT and Galectin-1 in Retinal Diseases (2024)

[NN4101]

[Cardiovasc Res.] Stem cell factor and cKIT modulate endothelial glycolysis in hypoxia (2024)

[NN4101]

[ARVO Poster] The novel function of NN2101, an anti-c-kit antibody, as an inhibitor of HIF via c-kit regulation in ocular neovascular disease (2022)

[NN4101]

[Pharmaceutics] A Fully Human Monoclonal Antibody Targeting cKIT Is a Potent Inhibitor of Pathological CNV in Mice (2021)

[NN4101]

[ARVO Poster] A Fully Human Monoclonal Antibody Targeting c-KIT is a Potent Inhibitor of Choroidal Neovascularization in a Murine Model (2021)

[NN4101]

[IJBIOMAC] Development and characterization of a fully human antibody targeting SCF/c-kit signaling (2020)

[NN4101]

[ATVB] SCF (Stem Cell Factor) and cKIT Modulate Pathological Ocular Neovascularization (2019)

[NN4101]

[Mol Vis.] Src tyrosine kinase regulates the stem cell factor-induced breakdown of the blood-retinal barrier (2016)

[NN4101]

[ATVB] Stem Cell Factor Is a Potent Endothelial Permeability Factor (2014)

[NN4101]

[Cardiovasc Res.] Direct and Differential Effects of Stem Cell Factor on the Neovascularization Activity of Endothelial Progenitor Cells (2011)